Mural Oncology Statistics
Total Valuation
Mural Oncology has a market cap or net worth of $21.36 million. The enterprise value is -$115.34 million.
Important Dates
The last earnings date was Tuesday, March 11, 2025, before market open.
Earnings Date | Mar 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Mural Oncology has 17.23 million shares outstanding. The number of shares has increased by 1.59% in one year.
Current Share Class | 17.23M |
Shares Outstanding | 17.23M |
Shares Change (YoY) | +1.59% |
Shares Change (QoQ) | +0.24% |
Owned by Insiders (%) | 0.41% |
Owned by Institutions (%) | 29.06% |
Float | 12.90M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.15 |
P/TBV Ratio | 0.15 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.84, with a Debt / Equity ratio of 0.06.
Current Ratio | 5.84 |
Quick Ratio | 5.53 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.57% and return on invested capital (ROIC) is -40.44%.
Return on Equity (ROE) | -63.57% |
Return on Assets (ROA) | -36.68% |
Return on Invested Capital (ROIC) | -40.44% |
Return on Capital Employed (ROCE) | -96.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.11M |
Employee Count | 116 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.85% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -74.85% |
50-Day Moving Average | 3.60 |
200-Day Moving Average | 3.45 |
Relative Strength Index (RSI) | 18.94 |
Average Volume (20 Days) | 423,726 |
Short Selling Information
The latest short interest is 406,115, so 2.36% of the outstanding shares have been sold short.
Short Interest | 406,115 |
Short Previous Month | 355,753 |
Short % of Shares Out | 2.36% |
Short % of Float | 3.15% |
Short Ratio (days to cover) | 4.53 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -138.26M |
Pretax Income | n/a |
Net Income | -128.51M |
EBITDA | -134.75M |
EBIT | -138.26M |
Earnings Per Share (EPS) | -$7.58 |
Full Income Statement Balance Sheet
The company has $144.39 million in cash and $8.02 million in debt, giving a net cash position of $136.36 million or $7.92 per share.
Cash & Cash Equivalents | 144.39M |
Total Debt | 8.02M |
Net Cash | 136.36M |
Net Cash Per Share | $7.92 |
Equity (Book Value) | 140.50M |
Book Value Per Share | 8.22 |
Working Capital | 126.72M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$128.55 million and capital expenditures -$92,000, giving a free cash flow of -$128.64 million.
Operating Cash Flow | -128.55M |
Capital Expenditures | -92,000 |
Free Cash Flow | -128.64M |
FCF Per Share | -$7.47 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |